Ingvild S. Leikfoss

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

SARS-CoV-2 T-cell vaccine VB10.2210 induces broad T-cell responses in a phase 1/2 open-label clinical trial.

SARS-CoV-2 T-cell vaccine VB10.2210 induces broad T-cell responses in a phase 1/2 open-label clinical trial.

Journal: Vaccine
Published: October 01, 2025

Epigenome-wide association study of peripheral immune cell populations in Parkinson's disease.

Epigenome-wide association study of peripheral immune cell populations in Parkinson's disease.

Journal: NPJ Parkinson's disease
Published: June 13, 2023

Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis.

Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: June 06, 2022

Quantitative proteomics reveals protein dysregulation during T cell activation in multiple sclerosis patients compared to healthy controls.

Quantitative proteomics reveals protein dysregulation during T cell activation in multiple sclerosis patients compared to healthy controls.

Journal: Clinical proteomics
Published: September 03, 2021

Global DNA methylation changes in treated and untreated MS patients measured over time.

Global DNA methylation changes in treated and untreated MS patients measured over time.

Journal: Journal of neuroimmunology
Published: April 26, 2021

CD8+ T cell gene expression analysis identifies differentially expressed genes between multiple sclerosis patients and healthy controls.

CD8+ T cell gene expression analysis identifies differentially expressed genes between multiple sclerosis patients and healthy controls.

Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: June 23, 2020

Exploring the role of the multiple sclerosis susceptibility gene CLEC16A in T cells.

Exploring the role of the multiple sclerosis susceptibility gene CLEC16A in T cells.

Journal: Scandinavian journal of immunology
Published: June 23, 2020

No differential gene expression for CD4+ T cells of MS patients and healthy controls.

No differential gene expression for CD4+ T cells of MS patients and healthy controls.

Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: December 07, 2018

The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells.

The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells.

Journal: Genes and immunity
Published: May 05, 2015

Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells.

Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells.

Journal: PloS one
Published: March 24, 2015

Retinoic acid enhances the levels of IL-10 in TLR-stimulated B cells from patients with relapsing-remitting multiple sclerosis.

Retinoic acid enhances the levels of IL-10 in TLR-stimulated B cells from patients with relapsing-remitting multiple sclerosis.

Journal: Journal of neuroimmunology
Published: September 09, 2014

Genome-wide DNA methylation profiles indicate CD8+ T cell hypermethylation in multiple sclerosis.

Genome-wide DNA methylation profiles indicate CD8+ T cell hypermethylation in multiple sclerosis.

Journal: PloS one
Published: July 21, 2014
Showing 1-12 of 15

Last Updated: 09/26/2026